Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Patient-centered Care01:13

Patient-centered Care

Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs like...
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
Urinary Tract Calculi VI: Surgical Management01:25

Urinary Tract Calculi VI: Surgical Management

Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Urinary Tract Calculi V: Nursing Management01:28

Urinary Tract Calculi V: Nursing Management

AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Time toxicity of intravesical BCG versus sequential intravesical gemcitabine and docetaxel for non-muscle-invasive bladder cancer.

BJUI compass·2026
Same author

Cost-Effectiveness of Immune Checkpoint Inhibitor Therapy plus BCG for High-Risk Non-Muscle-Invasive Bladder Cancer: Analyses of CREST, POTOMAC, and ALBAN.

The Journal of urology·2026
Same author

Tumor-informed ctDNA surveillance after radical nephrectomy and level IV IVC thrombectomy for clear cell renal cell carcinoma: Early detection of molecular residual disease.

Urology case reports·2026
Same author

'BJUI Clinical Dilemma': Recurrent high-grade non-muscle-invasive bladder cancer in 2026.

BJU international·2026
Same author

High Risk Prostate Cancer: What is it?

The Urologic clinics of North America·2026
Same author

Editorial Comment.

The Journal of urology·2026
Same journal

An Unprecedented Era of Innovation in Non-Muscle-Invasive Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Hubert Humphrey's Bladder Cancer: If He Could Have Time Traveled, Would that Have Changed the Outcome?

The Urologic clinics of North America·2026
Same journal

Key Clinical Trials Shaping the Future of Superficial High-Risk Bladder Cancer Management.

The Urologic clinics of North America·2026
Same journal

Future Directions: Artificial Intelligence and Digital Tools in Bladder Cancer Care.

The Urologic clinics of North America·2026
Same journal

Economic Considerations in the Management of Superficial Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Impact of Social and Structural Determinants of Health on Bladder Cancer Outcomes: Focus on Non-Muscle-Invasive Disease.

The Urologic clinics of North America·2026
See all related articles
  1. Home
  2. Patient-centered Approaches To Non-muscle-invasive Bladder Cancer Care.
  1. Home
  2. Patient-centered Approaches To Non-muscle-invasive Bladder Cancer Care.

Related Experiment Video

Culture of Bladder Cancer Organoids as Precision Medicine Tools
08:39

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Published on: December 28, 2021

Patient-Centered Approaches to Non-Muscle-Invasive Bladder Cancer Care.

Melinda Z Fu1, Jennifer Sykes1, John Pfail1

  • 1Division of Urology, Department of Surgery, Rutgers Cancer Institute, New Brunswick, NJ, USA.

The Urologic Clinics of North America
|June 26, 2026

View abstract on PubMed

Summary
This summary is machine-generated.

Nonmuscle-invasive bladder cancer (NMIBC) affects many patients, causing significant burdens despite high survival rates. This review covers innovations in NMIBC treatment and strategies to improve patient quality of life.

Keywords:
Bladder sparing therapyIntravesical therapyNMIBCQuality of lifeTURBT

Related Experiment Videos

Culture of Bladder Cancer Organoids as Precision Medicine Tools
08:39

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Published on: December 28, 2021

Area of Science:

  • Oncology
  • Urology

Background:

  • Nonmuscle-invasive bladder cancer (NMIBC) accounts for 75%-80% of bladder cancer cases.
  • NMIBC is a chronic condition with high recurrence rates, requiring lifelong surveillance and interventions.
  • Patients face physical, psychological, and financial burdens due to monitoring and treatment.

Purpose of the Study:

  • To review current treatment cornerstones for NMIBC, including transurethral resection of bladder tumors (TURBT) and adjuvant intravesical therapy.
  • To discuss innovations in NMIBC treatment, focusing on novel agents and techniques.
  • To explore symptom management and quality of life enhancement for NMIBC patients.

Main Methods:

  • Literature review of NMIBC treatment modalities and innovations.
  • Discussion of current therapeutic approaches and emerging technologies.
  • Focus on patient-centered care, including symptom management and quality of life.
  • Main Results:

    • TURBT and adjuvant intravesical therapy remain standard NMIBC treatments.
    • Innovations in agents and techniques are emerging for NMIBC management.
    • Symptom management and quality of life are critical aspects of NMIBC care.

    Conclusions:

    • Despite favorable survival, NMIBC imposes significant patient burdens.
    • Advancements in treatment and supportive care are crucial for improving outcomes and quality of life in NMIBC patients.
    • Lifelong surveillance and management strategies are essential for this chronic condition.